Objective: We sought to assess the angiographic and long‐term clinical outcomes in a predominantly medically treated population with spontaneous coronary artery dissection (SCAD).
Objectives: The aim of this study was to evaluate midterm outcomes of bioresorbable vascular scaffolds (BVS) implanted in bifurcation lesions.
Objective: To compare second generation drug eluting stents (2DES) with first generation (1DES) for the treatment of patients (pts) with multiple coronary vessel disease (MVD).
Objectives: We sought to identify angiographic predictors of 2‐year stent thrombosis (ST) in the ADAPT‐DES study.
Objectives: This study aimed to investigate the long‐term outcomes following mini‐crush versus culotte stenting with drug‐eluting stents (DES) for the treatment of unprotected left main coronary artery (LMCA) disease.
Objectives: To evaluate the long‐term prognostic value of risk scores in the setting of drug‐eluting stent (DES) implantation for uLMCA.
Background: Transcatheter aortic valve implantation (TAVI) has been demonstrated to be an effective alternative to surgical aortic valve replacement (SAVR) in patients with aortic stenosis who are deemed high risk or inoperable. Currently, TAVI procedures in China mostly make use of the domestic Venus A‐Valve and the CoreValve; however, there is no data on their comparative performance.
Objectives: We sought to study whether the level of completeness of revascularization as measured by the SYNTAX revascularization index (SRI) independently predicts adverse ischemic events after percutaneous coronary intervention (PCI) with second‐generation drug‐eluting stents (DES).
Objectives: This retrospective, single‐center, observational analysis from prospectively collected database evaluated whether left dominance affected the long‐term outcomes of acute coronary syndrome patients undergoing percutaneous coronary intervention, and whether the effect was independent of SYNTAX score.
Objective: This study sought to compare the clinical outcomes of 6‐month versus 12‐month dual antiplatelet therapy (DAPT) in patients receiving multiple biodegradable polymer‐coated sirolimus‐eluting stents (BP‐SES) implants.
Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug‐eluting stent (DES) implantation remains undetermined, especially for those at high risk of cardiac events postprocedure.
Objectives: To determine whether successful percutaneous coronary intervention (PCI) using drug‐eluting stents (DESs) have beneficial effects on long‐term outcomes in patients with chronic total occlusions (CTOs) compared with failed PCIs for CTOs.
Objectives: To compare stent coverage and malapposition in patients with chronic total occlusion (CTO) lesions and non‐CTO lesions (including lipid‐rich plaque [LRP] and non‐lipid‐rich plaque [non‐LRP]) after drug‐eluting stent (DES) implantation by optical coherence tomography (OCT).
Objectives: To compare vascular healing after drug‐eluting stent (DES) implantation between plaque rupture (PR) and plaque erosion (PE).
Objectives: To evaluate the safety and feasibility of subclavian artery stenting for coronary‐subclavian steal syndrome (CSSS).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos